Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization

In Vivo

Volumn 21, Issue 2, 2007, Pages 141-146

  Greenberger, Joel S ^a   Epperly, Michael W ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antioxidant pool; MnSOD plasmid liposomes; Radiosensitization; Redox balance; Review

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMIFOSTINE; ANTIBIOTIC AGENT; ANTIOXIDANT; BETAFECTIN; CARBOPLATIN; CISPLATIN; COLONY STIMULATING FACTOR 1; CYTOKINE; DOCETAXEL; ERYTHROPOIETIN; ETOPOSIDE; GLUTAMINE; GLUTATHIONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROPHAGE ACTIVATING FACTOR; MANGANESE SUPEROXIDE DISMUTASE; PALIFERMIN; PENTOXIFYLLINE; PILOCARPINE; PLATINUM COMPLEX; TAXANE DERIVATIVE; RADIOPROTECTIVE AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; DENSITOMETRY; DRUG BIOAVAILABILITY; HEAD AND NECK CANCER; LEWIS CARCINOMA; MOUTH FLORA; MUCOSA INFLAMMATION; NONHUMAN; OSTEOPOROSIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROMOTER REGION; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIZATION; REGULATOR GENE; REVIEW; SIALOADENITIS; STOMATITIS; VIRAL GENE DELIVERY SYSTEM; XEROSTOMIA; ANIMAL; GENE THERAPY; HUMAN; LUNG TUMOR; METHODOLOGY; MOUSE; NEOPLASM;

ANIMALS; ANTIOXIDANTS; GENE THERAPY; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASMS; RADIATION-PROTECTIVE AGENTS;

EID: 34047234150     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Greenberger JS, Kagan VE, Pearce L, Boriseniao G and Epperly MW: Modulation of redox signal transduction pathways in the treatment of cancer. Antioxidants Redox Signaling 3(3): 347-359, 2001.
2. Oberley LW and Buettner GR: Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141-1149, 1979.
3. Oberley LW and Oberley TD: Free radicals, cancer, and aging. In: Free radicals, aging, and degenerative diseases. Johnson JE Jr., Walford R, Harmon D, Miquel J (eds). Alan R. Liss, Inc., pp. 325-381, 1986.
4. Li S, Yan T, Yang J-Q, Oberley TD and Oberley LW: The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
5. 2-resistant Chinese hamster fibroblasts. Archiv Biochem Biophys 279: 249-260, 1990.
6. Amstad P, Moret R and Cerutti P: Glutathione peroxidase compensates for the hypersensitivity of Cu, Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem 269(3): 1606-1609, 1994.
7. Kelner MJ, Bagnell R, Montoya M, Estes L, Uglik SF and Cerutti P: Transfection with human copper zinc superoxide dismutase induces bi-directional alterations in other antioxidant enzymes, proteins, growth factor response, and paraquat resistance. Free Radic Biol Med 18(3): 497-506, 1995.
8. Amstad P, Peskin A, Shah G, Mirault M-E, Moret R, Zbinden I and Cerutti P: The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochem 30: 9305-9313, 1991.
9. Larsson R and Cerutti P: Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res 49(20): 5627-5632, 1989.
10. Ceriello A, dello Russo P, Amstad P and Cerutti P: High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 45(4): 471-477, 1996.
11. Schmidt KN, Amstad P and Cerutti P: The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol 2: 13-22, 1995.
12. Epperly MW, Travis EL, Sikora C and Greenberger JS: Manganese superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-1, TNF-α, and TGF-β correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant 5: 204-214, 1999.
13. Epperly MW, Gretton JA, DeFilippi SJ, Sikora CA, Liggitt D, Koe G and Greenberger JS: Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD-PL) gene therapy. Radiat Res 155: 2-14, 2001.
14. Epperly MW, Sikora C, Defilippi S, Bray J, Koe G, Liggitt D, Luketich JD and Greenberger JS: Plasmid/liposome transfer of the human manganese superoxide dismutase (MnSOD) transgene prevents ionizing irradiation-induced apoptosis in human esophageal organ explant culture. Int J Cancer (Radiat Oncol Invest) 90(3): 128-137, 2000.
15. Epperly MW, Bray JA, Esocobar P, Bigbee WL, Watkins S and Greenberger JS: Overexpression of the human MnSOD transgene in subclones of murine hematopoietic progenitor cell line 32D cl 3 decreases irradiation-induced apoptosis but does not alter G2/M or G1/S phase cell cycle arrest. Radiat Oncol Invest Clin Basic Res 7: 331-342, 1999.
16. Epperly MW, Sikora C, Defilippi S, Gretton J, Zhan Q, Kufe DW and Greenberger JS: Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat Res 157(5): 568-577, 2002.
17. Epperly MW, Bray JA, Krager S, Berry LA, Gooding W, Engelhardt JF, Zwacka R, Travis EL and Greenberger JS: Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Phys 43(1): 169-181, 1999.
18. Li S, Yan T, Yang JQ, Oberley TD and Oberley LW: The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
19. Epperly MW, Gretton JE, Sikora CA, Jefferson M, Bernarding M, Nie S and Greenberger JS: Mitochondrial localization of superoxide dismutase is required for decreasing irradiation-induced cellular damage. Radiat Res 160: 568-578, 2003.
20. Epperly MW, Bernarding M, Gretton J, Jefferson M, Nie S and Greenberger JS: Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF-α, IL-3 withdrawal and ionizing irradiation. Exp Hematol 31(6): 465-474, 2003.
21. Epperly MW, Defilippi S, Sikora C, Gretton J, Kalend K and Greenberger JS: Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther 7(12): 1011-1018, 2000.
22. Guo HL, Epperly MW, Bernarding M, Nie S, Gretton J, Jefferson M and Greenberger JS: Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) intratracheal gene therapy reduction of irradiation-induced inflammatory cytokines does not protect orthotopic Lewis lung carcinomas. In Vivo 17: 13-22, 2003.
23. Weydert CJ, Smith BB, Xu L, Kregel KC, Ritchie JM, Davis CS and Oberley LW: Inhibition of oral cancer cell growth by adenovirus MnSOD plus BCNU treatment. Free Radic Biol Med 34(3): 316-329, 2003.
24. Liu R, Buettner GR and Oberley LW: Oxygen free radicals mediate the induction of manganese superoxide dismutase gene expression by TNF-α. Free Radic Biol Med 28(8): 1197-1205, 2000.
25. Wang HP, Qian SY, Schafer FQ, Domann FE, Oberley LW and Buettner GR: Phospholipid hydroperoxide glutathione peroxidase protects against singlet oxygen-induced cell damage of photodynamic therapy. Free Radic Biol Med 30(8): 825-835, 2001.
26. Zhao W, Spitz DR, Oberley LW and Robbins MEC: Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing irradiation. Cancer Res 61: 5537-5543, 2001.
27. Zhong W, Yan T, Lim R and Oberley LW: Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic Biol Med 27(11/12): 1334-1345, 1999.
28. Li S, Yan T, Yan J-Q, Oberley TD and Oberley LW: The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
29. Zhang Y, Zhao W, Zhang HJ, Domann FE and Oberley LW: Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 62: 1205-1212, 2002.
30. Li Z, Khaletskly A, Wang J, Wong JYC, Oberley LW and Li JJ: Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase. Free Radic Biol Med 30(3): 260-267, 2001.
31. Cohen EEW, Rosen F, Stadler WM, Recant W, Stenson K, Huo D and Vokes EE: Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21(10): 1980-1987, 2003.
32. Kanemura T, Suzuki H, Aoshiba K, Yokohori N and Nagai A: Acute lung injury in lung cancer patients treated with ZD1839 and bleomycin-induced pulmonary fibrosis in mice. Proc Am Soc Clin Oncol 22: 652, 2003.
33. Khalil MY, Grandis JR and Shin DM: Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer. Expert Rev Anticancer Therapy 3(3): 367-380, 2003.
34. Xu Y, Krishnan A, Wan SX, Majima H, Yeh C-C, Ludewig G, Kasarskis EJ and St. Clair DK: Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 18: 93-102, 1999.
35. St. Clair DK, Wan XS, Oberley TD, Muse KE and St. Clair WH: Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Molec Carcinogenesis 6: 238-242, 1992.
36. Kavanagh BD, Dent P, Schmidt-Ullrich RK, Chen P and Mikkelsen RB: Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res 149(6): 579-587, 1998.
37. Hagan MP, Yacoub A and Dent P: The switch from DNA repair to apoptosis: Discovery of a refractory period for radiation-induced EGFR-MAPK signaling following irradiation. IJROBP 57(2): Suppl #1050, 2003.
38. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R and Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing irradiation in A431 human squamous carcinoma cells. Oncogene 16: 2787-2796, 1998.
39. MAPK. Experimental Neurology 180: 144-155, 2003.
40. Kaimori J, Takenaka M, Nakajima H, Hamano T, Horio M, Sugaya T, Ito T, Hori M, Okubo K and Imai E: Induction of glia maturation factor-B in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem 278(35): 33519-33527, 2003.
41. Naderi J, Hung M and Pandey S: Oxidative stress-induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and overexpression of Bax: Resistance of quiescent cells to oxidative stress. Apoptosis 8: 91-100, 2003.
42. Takeyanna K, Dabbagh K, Shim JJ, Dan-Pick T, Ueki IF and Nadel JA: Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164: 1546-1552, 2000.
43. Guo H, Seixas-Silva J, Epperly MW, Gretton JE, Shin DM, Bar-Sagi D, Archer H and Greenberger JS: Prevention of irradiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (MnSOD) transgene. Radia Res 159: 361-370, 2003.
44. Epperly MW, Bray JA, Kraeger S, Zwacka R, Engelhardt J, Travis E and Greenberger JS: Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Therapy 5: 196-208, 1998.
45. Greenberger JS, Bahri S, Jett J, Belani C, Kalend A and Epperly MW: Considerations in optimizing radiation therapy for non-small cell lung cancer. (International Symposium on Thoracic Malignancies). Chest 113(1): 465-525, 1998.
46. Zwacka RM, Dudus L, Epperly MW, Greenberger JS and Engelhardt JF: Redox gene therapy protects human 1B-3 lung epithelial cells against ionizing radiation-induced apoptosis. Human Gene Therapy 9: 1381-1386, 1998.
47. Stickle RL, Epperly MW, Klein E, Bray JA and Greenberger JS: Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase (MnSOD) transgene. Radiat Oncol Invest Clin Basic Res 7(6): 204-217, 1999.
48. Epperly MW, Kagan VE, Sikora CA, Gretton JE, Defilippi SJ, Bar-Sagi D and Greenberger JS: Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated irradiation. Int J Cancer (Radiat Oncol Invest) 96: 221-231, 2001.
49. Epperly MW, Epstein CJ, Travis EL and Greenberger JS: Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnS0D)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiation Res 154(4): 365-374, 2000.
50. Epperly MW, Travis EL, Whitsett JA, Epstein CJ and Greenberger JS: Overexpression of manganese superoxide dismutase (MnSOD) in whole lung or alveolar type II (AT-II) cells of MnSOD transgenic mice does not provide intrinsic lung irradiation protection. Radiat Oncol Invest 96: 11-21, 2001.
51. Kies MS, Haraf DJ, Rosen F, Stenson K, List M, Brockstein B, Chung T, Mittal BB, Peizer H, Portugal L, Rademaker A, Weichselbaum R and Vokes EE: Concomitant infusional docitaxol and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19(7): 1961-1969, 2001.
52. Martinez JC, Villlar A, Cabezon MA, DeSerdio JL, Fuentes C, Espineira M, Perez MD, Gil J, Artazkoz JJ, Borque C, Suner M and Saavedra JA: Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: A stepwise developed treatment schedule for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50(2): 377-385, 2001.
53. Dawson LA, Myers LL, Bradford CR, Chepeha DB, Hogikyan ND, Teknos TN, Terrell JE, Wolf GT and Eisbruch A: Conformal re-irradiation of recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phys 50(2): 377-385, 2001.
54. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, Le Veque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FKL and Horowitz M: Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol 19(8): 2201-2205, 2001.
55. Wijers OB, Levendag PC, Harris ER, Gan-Teng AM, Schmitz PIM, Hendriks WDH, Wilms EB, Van Der Est H and Visch LL: Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: A placebo-controlled double-blinded randomized study. Int J Radiat Oncol Biol Phys 50(1): 343-352, 2001.
56. Damron TA, Margulies B, Biskup D and Spadaro JA: WR2721 before fractionated irradiation protects bone growth in rats better than fractionation alone. Int J Radiat Oncol Biol Phys 50(1): 479-483, 2001.
57. Johnstone PA, Peng YP, May BC, Inouye WS and Niemtzow RC: Acupuncture for piocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys 50(2): 353-357, 2001.
58. Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE, Grubbs S, DeShields M and Curran WJ: Preliminary report on reduction of esophagitis by WR2721 in patients with non-small cell lung cancer treated with chemoradiotherapy. Clinical Lung Cancer 2(4): 284-289, 2001.
59. Ozturk B, Egehan I, Atavci S and Kitapci M: Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 58(1): 213-219, 2004.
60. Roesink JM, Konings AWT, Terhaard CHJ, Battermann JJ, Kampinga HH and Coppes RP: Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys 45(2): 483-489, 1999.
61. Astreinidou E, Dehnad H, Terhaard CHJ and Raaijmakers CPJ: Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 58(1): 124-131, 2004.
62. Ertekin MV, Koc M, Karslioglu I and Sezen O: Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: A prospective, placebo-controlled, randomized study. Int J Radiat Oncol Biol Phys 58(1): 167-174, 2004.
63. Horiot J-C, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, Bolla M, Coscas Y, Baillet F, Coche-Dequeant B, Urbajtel M, Montbarbon X, Bourdin S, Wibault P, Alfonsi M, Calais G, Desprez P, Pene F, Lapeyre M, Vinke J and Maral J: Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol 55: 233-239, 2000.
64. Huang E-Y, Leung SW, Wang C-J, Chen H-C, Sun L-M, Fang F-M, Yeh S-A, Hsu H-C and Hsiung C-Y: Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 46(3): 535-539, 2000.
65. Vanhoefer U, Tewes M, Rojo F, Dirsch O, Schleucher N, Rosen O, Tillner J, Kovar A, Braun AH, Trarbach T, Seeber S, Harstrick A and Baselga J: Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. J Clin Oncol 22: 175-184, 2004.
66. Stiff P, Bensinger W, Emmanouilides C, Gentile T, Weisdorf D, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, Rong A, Erder MH and Spielberger R: Treatment of mucositis with palifermin improves patient function and results in a clinically meaningful reduction in mouth and throat soreness (MTS): Phase 3 results. Blood 102 (11): 194a, 2003.
67. Emmanuouilides C, Spielberger R, Stiff P, Rong A, Isitt J, Bensinger W, Weisdorf D, Gentile T, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, Aycock J and Erder MH: Palifermin treatment of mucositis in transplant patients reduces health resource use: Phase 3 results. Blood 102 (11): 251a, 2003.
68. Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, Strottmann J, Pulmano C and Mohiuddin M: High dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 19(14): 333-3339, 2001.
69. Maurici D, Monti P, Campomenosi P, North S, Frebourg T, Fronza G and Hainaut P: WR2721 (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20: 3533-3540, 2001.
70. Makkonen TA, Minn H, Jekunen A, Vilja P, Tuominen J and Joensuu H: Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study. Int J Radiat Oncol Biol Phys 46(3): 525-534, 2000.
71. Munter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M and Debus J: Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 58(1): 175-184, 2004.
72. Kanai AJ, Zeidel ML, Lavelle JP, Greenberger JS, Birder LA, de Groat WC, Apodaca GL, Meyers SA, Ramage R, VanBibber MM and Epperly MW: Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis. Am J Physiology (Renal Physiology) 44: 1152-1160, 2002.
73. Guo HL, Wolfe D, Epperly MW, Huang S, Liu K, Glorioso JC, Greenberger J and Blumberg D: Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg 7: 229-236, 2003.